Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | AZN | AMGN | GILD | BMY |
| Company | Halozyme Therapeutic | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 70.66 | 204.60 | 375.26 | 148.93 | 60.97 |
| High | 71.33 | 207.31 | 380.09 | 152.46 | 61.44 |
| Low | 69.80 | 204.34 | 374.74 | 148.38 | 60.64 |
| Latest | 70.83 | 206.43 | 379.06 | 149.87 | 61.10 |
| Change | -0.15 | +2.23 | +4.31 | -1.53 | +0.44 |
| % Change | -0.21% | +1.09% | +1.15% | -1.01% | +0.73% |
| Volume | 386,532 | 683,470 | 710,706 | 1,953,682 | 3,415,183 |
| 20-Day Average Volume | 2,239,480 | 2,826,646 | 2,947,881 | 7,835,234 | 12,749,970 |
| Previous Close | 70.98 | 204.20 | 374.75 | 151.40 | 60.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 75.52 | 195.51 | 362.65 | 147.81 | 58.47 |
| 20-Day Raw Stochastic | 13.46% | 76.56% | 83.79% | 69.01% | 88.90% |
| 20-Day Relative Strength | 45.06 | 62.70 | 63.22 | 61.74 | 65.52 |
| Weighted Alpha | +19.80 | +44.53 | +31.79 | +41.53 | +16.66 |
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.06% since 02/13/26 | +0.17% since 02/13/26 | +2.25% since 02/13/26 | -3.23% since 02/13/26 | +0.72% since 02/13/26 |
| Low | 70.17 on 02/23/26 | 204.05 on 02/20/26 | 369.00 on 02/17/26 | 148.85 on 02/23/26 | 59.23 on 02/19/26 |
| High | 81.51 on 02/17/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.01 on 02/18/26 | 61.43 on 02/23/26 |
| 1-Month | |||||
| %Chg | +2.07% since 01/23/26 | +10.76% since 01/23/26 | +9.50% since 01/23/26 | +10.33% since 01/23/26 | +11.95% since 01/23/26 |
| Low | 68.85 on 01/26/26 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 133.69 on 01/26/26 | 54.21 on 01/29/26 |
| High | 82.22 on 02/09/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +0.44% since 11/21/25 | +13.13% since 11/21/25 | +11.84% since 11/21/25 | +18.43% since 11/21/25 | +32.28% since 11/21/25 |
| Low | 61.22 on 12/11/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 47.58 on 11/24/25 |
| High | 82.22 on 02/09/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -1.63% since 08/22/25 | +27.14% since 08/22/25 | +28.52% since 08/22/25 | +30.67% since 08/22/25 | +27.67% since 08/22/25 |
| Low | 61.22 on 12/11/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 82.22 on 02/09/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,376,846 | 316,695,392 | 202,015,744 | 187,838,960 | 123,532,512 |
| Shares Outstanding, K | 118,017 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 1,015,320,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 444,090,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 354,260,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 175,230,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.97 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 02/17/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 19.06 | 25.76 | 17.19 | 18.54 | 9.80 |